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Inclusion of end-of-life care in the global health agenda 
Global development, strengthening of health systems, 
and an increase in access to treatments will improve 
health outcomes. However, the global need for palliative 
and end-of-life care will persist. As populations age and 
societies industrialise, the number of people who will 
need palliative care to manage the problems associated 
with chronic progressive illness, e specially cancer, 
are predicted to increase in low-income and middle-
income countries. This increase is compounded by late 
presentation to medical services and restricted access to 
potentially curative options. 
The provision of palliative and end-of-life care, 
including access to pain relief, is a worldwide human 
right within existing covenants.1 However, three 
documents have shown the woefully inadequate 
coverage in most regions. First, a worldwide classiﬁ cation 
of every country’s level of palliative care provisions 
showed that only 58% of countries have a palliative care 
service, and provision ratios are as poor as one service 
per 90 million population.2 Second, WHO’s 2014 global 
atlas of palliative care reported that less than 10% of the 
20 million people every year who need palliative care at 
the end of life actually receive it, and although most care 
is delivered in high-income countries, 80% of people 
who need palliative care are in low-income and middle-
income countries.3 Third, in 2012, the International 
Agency for Research on Cancer’s GLOBOCAN published 
its ﬁ rst global cancer estimates for 4 years,4 and reported 
5·3 million deaths from cancer in less-developed regions 
during 2012. 
Clearly, provision of appropriate end-of-life care is 
inadequate in low-income and middle-income countries. 
WHO’s Public Health Strategy for Palliative Care has 
provided an important framework to assist countries to 
put into place the necessary actions to be able to provide 
their citizens with the palliative and end-of-life care that 
they need (ie, drug availability for pain and symptom 
relief, education of clinicians, and delivery of health-care 
policy that includes provision at the end of life). 
The strategic approach at our Cicely Saunders Institute 
(King’s College London, UK) towards global programmes 
and partnerships in palliative and end-of-life care has 
been led by a fundamental belief that, for this strategy 
to succeed, it needs to be underpinned by locally 
generated evidence. WHO’s deﬁ nition of palliative 
care (ie, the assessment and control of physical, 
psychological, social, and spiritual problems in patients 
and their families from diagnosis, until the end of life, 
and into bereavement) is broadly accepted worldwide. 
However, strategic responses need to be based on 
evidence of local preferences and priorities at the end 
of life, to take account of local regulatory environments 
with respect to opioid use, and to be responsive to local 
cultural beliefs and health systems.
The evidence base for palliative care has been mostly 
generated in high-income countries; however, evidence 
speciﬁ c to low-income and middle-income countries 
has started to be developed. For example, with respect 
to policy, health economic studies suggested that costs 
associated with palliative care were lower in high-
income countries than in lower-income countries, and 
that this cost saving can be achieved by hospital-based 
palliative care services.5 In terms of drug availability, 
although advocacy focuses largely on opioid availability, 
in east African pharmacies even non-opioid analgesics 
have interrupted supply.6 With respect to education, 
in patients with advanced cancer in Cuba, fewer than 
half were aware of their diagnosis, and only 9% knew 
that they were dying,7 and in Bangladesh futile active 
treatment is encouraged for those who can rarely aﬀ ord 
it.8 Evidence from high-income countries suggests that 
people prefer to die at home, yet this is not the case in 
Africa, which suggests that preferences are aﬀ ected by 
resource availability.9 The global health palliative care 
agenda needs to not only follow high-income countries’ 
research agenda into other progressive conditions 
such as patients with heart failure, chronic obstructive 
pulmonary disease, and renal failure, but also to develop 
the evidence urgently needed to respond to locally 
prevalent disease, such as drug-resistant tuberculosis.10 
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